We are live on ! Find out more
Adage Capital Partners

Adage Capital Partners Portfolio holdings

AUM $64.8B
1-Year Est. Return 42.7%
This Fund
S&P 500
This Quarter Est. Return
+5.26%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+879.75%
AUM
$57.2B
AUM Growth
+$551M
Cap. Flow
-$331M
Cap. Flow %
-0.58%
Top 10 Hldgs %
31.76%
Holding
1,006
New
143
Increased
295
Reduced
385
Closed
137

Sector Composition

Rank Sector Weight
1 Technology 29.09%
2 Healthcare 13.87%
3 Financials 11.48%
4 Consumer Discretionary 10.65%
5 Industrials 8.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARE icon
876
Alexandria Real Estate Equities
ARE
$8.28B
-1,700
Closed -$202K
ARWR icon
877
Arrowhead Research
ARWR
$12.6B
-350,000
Closed -$6.78M
ASND icon
878
Ascendis Pharma A/S
ASND
$16.7B
-486,957
Closed -$72.7M
AUTL
879
Autolus Therapeutics
AUTL
$620M
-2,950,000
Closed -$10.7M
BALL icon
880
Ball Corp
BALL
$16.6B
-288,322
Closed -$19.6M
BALY icon
881
Bally's
BALY
$635M
-127,144
Closed -$2.19M
BAX icon
882
Baxter International
BAX
$14.3B
-1,563,567
Closed -$59.4M
BCO icon
883
Brink's
BCO
$4.69B
-20,839
Closed -$2.41M
BEN icon
884
Franklin Resources
BEN
$16.9B
-265,900
Closed -$5.36M
BIIB icon
885
Biogen
BIIB
$30.1B
-45,799
Closed -$8.88M
BLD
886
DELISTED
TopBuild
BLD
-5,000
Closed -$2.03M
BNTX icon
887
BioNTech
BNTX
$23.3B
-57,500
Closed -$6.83M
BOLT icon
888
Bolt Biotherapeutics
BOLT
$7.65M
-25,000
Closed -$324K
CATX icon
889
Perspective Therapeutics
CATX
$363M
-750,000
Closed -$10M
CENX icon
890
Century Aluminum
CENX
$5.18B
-10,000
Closed -$162K
CFG icon
891
Citizens Financial Group
CFG
$30.7B
-62,619
Closed -$2.57M
CPB icon
892
Campbell Soup
CPB
$6.78B
-43,346
Closed -$2.12M
CPRI icon
893
Capri Holdings
CPRI
$1.77B
-749,133
Closed -$31.8M
CRH icon
894
CRH
CRH
$67.4B
-222,000
Closed -$20.6M
CRVO icon
895
CervoMed
CRVO
$41.8M
-28,600
Closed -$418K
CTMX icon
896
CytomX Therapeutics
CTMX
$752M
-3,000,000
Closed -$3.54M
CXT icon
897
Crane NXT
CXT
$2.95B
-720,485
Closed -$40.4M
CYBR
898
DELISTED
CyberArk
CYBR
-20,000
Closed -$5.83M
D icon
899
Dominion Energy
D
$59.9B
-265,811
Closed -$15.4M
DOCU
900
DocuSign
DOCU
$11.3B
-25,000
Closed -$1.55M

Similar funds

Adage Capital Partners's Q4 2024 Portfolio in Review

As of Q4 2024, Adage Capital Partners held 1,006 positions worth $57.2B, up 0.97% from $56.6B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Adage Capital Partners's Q4 2024 filing shows 143 new, 295 increased, 385 reduced and 137 closed positions. Its largest new stake was Gilead Sciences: 1,714,130 shares worth $158M. The largest sale was Marathon Oil Corporation, an estimated $221M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 28% a quarter earlier, followed by Healthcare and Financials.

  • Adage Capital Partners's largest Q4 2024 buy was Gilead Sciences: 1,714,130 shares worth $158M.
  • Adage Capital Partners added most to ConocoPhillips in Q4 2024, an estimated $247M increase.
  • Adage Capital Partners's biggest Q4 2024 reduction was 3M, cutting an estimated $157M.
  • Adage Capital Partners fully exited Marathon Oil Corporation in Q4 2024, selling an estimated $221M.
  • Adage Capital Partners's ten largest holdings make up 32% of its $57.2B portfolio in Q4 2024.
  • Adage Capital Partners opened 143 new positions and closed 137 in Q4 2024.
  • Adage Capital Partners's portfolio value rose 0.97% quarter-over-quarter to $57.2B.

Based on Adage Capital Partners's 13F filing for Q4 2024, filed 14 Feb 2025.